ReadyGo Diagnostics Ltd. Announces Development of Innovative Monkey Pox Virus Detection Assay
Bath, UK, September 10, 2024 – ReadyGo Diagnostics Ltd., a leader in rapid diagnostic solutions, is proud to announce the development of an innovative single-tube Monkey pox (Mpox) virus detection assay.
This groundbreaking assay is a result of ReadyGo Diagnostics’ cutting-edge expertise in point-of-care testing, aimed at addressing the urgent need for swift and accurate diagnostics in response to the escalating Mpox threat.
The new assay, designed for rapid results in under 20 minutes, seamlessly integrates with ReadyGo’s SnapCollect sample collection and processing consumable, known for its effectiveness in capturing and processing viruses from saliva. The test can be deployed on ReadyGo’s affordable Geo molecular platform or used as a standalone kit compatible with traditional laboratory-based molecular platforms. By utilizing Meridian Bioscience Inc.’s Air-Dryable Direct RNA/DNA LAMP Saliva (MDX137) reagents, this assay promises exceptional accuracy and reliability, crucial for effective patient isolation and treatment.
“We’re delighted to introduce this much-needed Mpox detection tool to the market,” said Dr. Ben Cobb, CEO of ReadyGo Diagnostics. “Our innovative approach harnesses the latest advancements in diagnostic technology to meet the urgent needs of healthcare providers globally. We have been working with Meridian’s innovative molecular reagents for some time, and our combined expertise will bring a powerful Mpox detection tool to the market.”
The Mpox assay will undergo rigorous testing to meet international standards and is scheduled to become available in September 2024. It will be accessible to healthcare providers and partners for distribution in cost-sensitive regions that require reliable point-of-care diagnostics. This assay is positioned to become a vital tool in early detection and outbreak management, playing a crucial role in protecting communities worldwide.
For media inquiries, please contact:
ReadyGo Diagnostics Ltd.
Ben Cobb, CEO
Ben Reed, CCO
Email: info@readygotest.com
www.readygotest.com
About ReadyGo Diagnostics Ltd.:
ReadyGo Diagnostics Ltd. is a leader in developing innovative rapid diagnostic tests designed to meet the demands of point-of-care settings worldwide. The company is committed to advancing healthcare through technology-driven solutions, ensuring timely and accurate diagnostics for a wide range of infectious diseases.
Derick is an experienced reporter having held multiple senior roles for large publishers across Europe. Specialist subjects include small business and financial emerging markets.